◆ Listed stock · GSK.L
GSK
Laboratoire pharmaceutique britannique (vaccins, VIH). Cotée sur Londres · LSE.
◆ Live market
…
24h
—
- Ticker
- GSK.L
- Category
- Stocks & ETFs
- Type
- Listed stock
- Group
- Londres · LSE
- Trading hours
- Market sessions
What is GSK?
Laboratoire pharmaceutique britannique (vaccins, VIH). Cotée sur Londres · LSE. A share represents part ownership of a listed company. Its price reflects investors' expectations of future earnings.
How GSK works and what gives it value
The stock reacts to quarterly results, management guidance, sector news and the rate backdrop. Earnings releases often cause big opening gaps.
What moves the price of GSK
- ◆Earnings and guidance
- ◆Interest rates
- ◆Sector news
- ◆Buybacks and dividends
Key metrics to watch
- ◆Revenue growth
- ◆Margins
- ◆P/E ratio
- ◆Earnings dates
Risks specific to GSK
- ◆Earnings disappointments
- ◆High valuation
- ◆Regulatory risk
How to analyse GSK on GraphTrade
Daily and weekly; market open only during sessions. Open the GSK.L chart, add the indicators below, compare GSK with similar assets in Performance and ask the AI Compass to explain the latest move with news and macro context.
Themes
Included in: Londres · LSE.
◆ Indicators suited to GSK
◆ FAQ
What is GSK (GSK.L)?
Laboratoire pharmaceutique britannique (vaccins, VIH). Cotée sur Londres · LSE.
Why is GSK going up or down today?
The main drivers are: earnings and guidance, interest rates, sector news, buybacks and dividends. The AI Compass cross-references these with today's news.
Which indicators work best on GSK?
Daily and weekly; market open only during sessions.
What are the risks of GSK?
Earnings disappointments ; High valuation ; Regulatory risk.
How do I follow GSK in real time?
Open the free GraphTrade chart for GSK.L: price updates live, with all indicators.
How do I add GSK to my portfolio?
Click « Add to portfolio » on this page: the asset joins your active portfolio.
Is this investment advice?
No. GraphTrade provides information and analysis tools only.
◆ Assets similar to GSK
Information only, not investment advice.